BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5301950)

  • 1. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity].
    Lobato DS; da Silveira DD
    Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950
    [No Abstract]   [Full Text] [Related]  

  • 2. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Model for clinico-pharmacological experimentation with an appetite depressant. Clinical trial with a delayed-action preparation].
    Strata A; Cucurachi L; Cucurachi P; Dell'anna A; Zuliani U
    Clin Ter; 1968 Mar; 44(6):495-516. PubMed ID: 4899457
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of an "anorexic" drug (phentermine-resin) in the treatment of obesity].
    Benedetti A; Busonera G; Cattano G
    Policlinico Prat; 1967 Nov; 74(48):1613-9. PubMed ID: 5611163
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of anoretics in weight reduction in obese patients].
    Pietrzak J; Krotkiewski M
    Pol Tyg Lek; 1971 May; 26(20):756-8. PubMed ID: 5580931
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 9. Appetite suppressants for obesity.
    Budenholzer B
    J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 11. New agent for obesity management.
    Schmitt SA
    J Fam Pract; 1996 Sep; 43(3):225. PubMed ID: 8797742
    [No Abstract]   [Full Text] [Related]  

  • 12. New agent for obesity management.
    Clemenson ND
    J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of obesity. A call for prudence and professionalism.
    Kushner R
    Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with a Hungarian-made chlorphentermine-type anorexigenig preparation (Desopimon) in the treatment of hypothalamopathies].
    Takács L; Pethö B
    Orv Hetil; 1969 Mar; 110(10):540-2. PubMed ID: 5779971
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new regulator of appetite: mefenorex].
    Vincendeau MJ
    Bord Med; 1970; 3(7):1951-3. PubMed ID: 5455004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chlorphentermine in the treatment of obesity].
    Chjnowski JR; Adamska-Dyniewska H; Leszczyński B; Mockallo T
    Pol Tyg Lek; 1968 Sep; 23(40):1531-3. PubMed ID: 5725611
    [No Abstract]   [Full Text] [Related]  

  • 18. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
    Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A treatment for refractory obesity using fenfluramine without dietary restriction.
    Sedgwick JP
    Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial of benzphetamine in treatment of obesity].
    Plauchu M; Chapuy H; Pousset G; Amourdedieu J; Tuaillon J
    Lyon Med; 1969 Sep; 222(32):317-20. PubMed ID: 5398817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.